Found: 55
Select item for more details and to access through your institution.
Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 4, p. 485, doi. 10.1111/ejh.14252
- By:
- Publication type:
- Article
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1.
- Published in:
- Frontiers in Pediatrics, 2024, p. 1, doi. 10.3389/fped.2024.1465166
- By:
- Publication type:
- Article
Variable bleeding phenotype in an Amish pedigree with von Willebrand disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E431, doi. 10.1002/ajh.24474
- By:
- Publication type:
- Article
Repeated recall as an intervention to improve memory performance in heart failure patients.
- Published in:
- European Journal of Cardiovascular Nursing, 2017, v. 16, n. 8, p. 724, doi. 10.1177/1474515117711610
- By:
- Publication type:
- Article
Clinical application of recommendations for neurobehavioral assessment in disorders of consciousness: an interdisciplinary approach.
- Published in:
- Frontiers in Human Neuroscience, 2023, p. 1, doi. 10.3389/fnhum.2023.1129466
- By:
- Publication type:
- Article
Cytomegalovirus (CMV) Retinitis Activity Is Accurately Reflected by the Presence and Level of CMV DNA in Aqueous Humor and Vitreous.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, n. 5, p. 1249, doi. 10.1086/314710
- By:
- Publication type:
- Article
Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 2005, v. 79, n. 3, p. 175, doi. 10.1002/ajh.20299
- By:
- Publication type:
- Article
Safety of high doses of a monoclonal antibody-purified factor IX concentrate.
- Published in:
- American Journal of Hematology, 1995, v. 49, n. 1, p. 92, doi. 10.1002/ajh.2830490117
- By:
- Publication type:
- Article
Excess of red cell membrane proteins in hereditary high-phosphatidylcholine hemolytic anemia.
- Published in:
- American Journal of Hematology, 1990, v. 34, n. 3, p. 186, doi. 10.1002/ajh.2830340306
- By:
- Publication type:
- Article
Final Results of the Prospective ADVATE<sup>®</sup> Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 991, doi. 10.2147/JBM.S329883
- By:
- Publication type:
- Article
Evaluation of an Educator-Delivered School-Based Stress Management Program for Adolescents.
- Published in:
- LEARNing Landscapes, 2017, v. 10, n. 2, p. 73, doi. 10.36510/learnland.v10i2.802
- By:
- Publication type:
- Article
Training Professionals in Delivering Evidence-based Cognitive Rehabilitation.
- Published in:
- Brain Injury Professional, 2021, v. 17, n. 4, p. 27
- By:
- Publication type:
- Article
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 232, doi. 10.1111/ejh.13731
- By:
- Publication type:
- Article
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Treatment of Nonsuicidal Self-Injury: Critical Review and Implications for School Applications.
- Published in:
- School Psychology Forum, 2013, v. 7, n. 4, p. 121
- By:
- Publication type:
- Article
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 1, p. 113, doi. 10.1111/bjh.13109
- By:
- Publication type:
- Article
Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1556, doi. 10.1111/hae.14849
- By:
- Publication type:
- Article
Psychometrics and applications of a novel self‐report measure of emicizumab adherence: VERITASNexGen.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1299, doi. 10.1111/hae.14851
- By:
- Publication type:
- Article
Severe FVII deficiency presenting with heterotopic gastric mucosa: hoofbeats may be a zebra.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 928, doi. 10.1111/hae.14782
- By:
- Publication type:
- Article
Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 423, doi. 10.1111/hae.14687
- By:
- Publication type:
- Article
Therapeutic and technological advancements in haemophilia care: Quantum leaps forward.
- Published in:
- Haemophilia, 2022, v. 28, p. 77, doi. 10.1111/hae.14531
- By:
- Publication type:
- Article
Therapeutic and technological advancements in haemophilia care: Quantum leaps forward.
- Published in:
- Haemophilia, 2022, v. 28, p. 77, doi. 10.1111/hae.14531
- By:
- Publication type:
- Article
Occurrence rates of inherited bleeding disorders other than haemophilia and von Willebrand disease among people receiving care in specialized treatment centres in the United States.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. e75, doi. 10.1111/hae.14529
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
- By:
- Publication type:
- Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 802, doi. 10.1111/hae.14357
- By:
- Publication type:
- Article
Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real‐world experience from a large comprehensive treatment centre in the US.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 90, doi. 10.1111/hae.14212
- By:
- Publication type:
- Article
Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 19, doi. 10.1111/hae.14192
- By:
- Publication type:
- Article
Natural history study of factor IX deficiency with focus on treatment and complications (B‐Natural).
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 49, doi. 10.1111/hae.14139
- By:
- Publication type:
- Article
Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 975, doi. 10.1111/hae.14152
- By:
- Publication type:
- Article
Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. e262, doi. 10.1111/hae.14036
- By:
- Publication type:
- Article
Adherence is a human behaviour, assessing it requires multimethod evaluation with validated measures: Comment on Guedes VG et al (2019).
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 934, doi. 10.1111/hae.14022
- By:
- Publication type:
- Article
Potential of the Community Counts registry to characterize rare bleeding disorders.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 1045, doi. 10.1111/hae.13847
- By:
- Publication type:
- Article
Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 1073, doi. 10.1111/hae.13842
- By:
- Publication type:
- Article
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. 867, doi. 10.1111/hae.13778
- By:
- Publication type:
- Article
Population‐based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 456, doi. 10.1111/hae.13734
- By:
- Publication type:
- Article
A promising on-demand treatment option for bleeding events in haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2017, v. 23, n. 6, p. 810, doi. 10.1111/hae.13345
- By:
- Publication type:
- Article
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 1603, doi. 10.2147/PPA.S141389
- By:
- Publication type:
- Article
A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 983, doi. 10.2147/PPA.S103874
- By:
- Publication type:
- Article
An investigation of the cognitive processes underlying the keyword method of foreign vocabulary learning.
- Published in:
- Language Teaching Research, 2005, v. 9, n. 2, p. 129, doi. 10.1191/1362168805lr151oa
- By:
- Publication type:
- Article
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE<sup>®</sup>) in the management of hemophilia A.
- Published in:
- Vascular Health & Risk Management, 2007, v. 3, n. 5, p. 555
- By:
- Publication type:
- Article
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label.
- Published in:
- 2016
- By:
- Publication type:
- journal article
MULTIMEDIA AND HYPERMEDIA SOLUTIONS FOR PROMOTING METACOGNITIVE ENGAGEMENT, COHERENCE, AND LEARNING.
- Published in:
- Journal of Educational Computing Research, 2005, v. 33, n. 1, p. 1, doi. 10.2190/7N6R-PCJL-UMHK-RYPJ
- By:
- Publication type:
- Article
Isolation and sequence of two genes associated with a CpG island 5′ of the factor VIII gene.
- Published in:
- Human Molecular Genetics, 1992, v. 1, n. 3, p. 179
- By:
- Publication type:
- Article
A Controlled Study of Clicker-Assisted Memory Enhancement in College Classrooms.
- Published in:
- Applied Cognitive Psychology, 2012, v. 26, n. 4, p. 635, doi. 10.1002/acp.2843
- By:
- Publication type:
- Article
Recombinant factor IX Fc for the treatment of hemophilia B.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 5, p. 678, doi. 10.1111/ejh.14176
- By:
- Publication type:
- Article
A past mutation at Isoleucine<sup>397</sup> is now a common cause of moderate/mild haemophilia B.
- Published in:
- British Journal of Haematology, 1990, v. 75, n. 2, p. 212, doi. 10.1111/j.1365-2141.1990.tb02651.x
- By:
- Publication type:
- Article
Priming correct information reduces the misinformation effect.
- Published in:
- Memory & Cognition, 2012, v. 40, n. 5, p. 717, doi. 10.3758/s13421-012-0191-7
- By:
- Publication type:
- Article